Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - May 2026
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Podcasts
    • Thought leadership
    • Letters to the Editor
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2025
    • Symposium 2024
    • Symposium 2023
    • Symposium 2022
    • Symposium 2021
    • Regulatory Careers Live
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - May 2026
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • interview_225322
      How to build a portfolio career: Stepping beyond the regulatory swim lane
    • SOFT main image
      Rethinking regulatory talent development
    • BASICS main image
      The drug development lifecycle: Regulatory milestones and pathways for early-career professionals
  • Veterinary
    • VET main image
      A career in veterinary regulatory affairs: Roles and competencies across the product lifecycle
    • Jana Schalansky
      November 2025 – Contents: Veterinary medicines sessions
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • RECRUIT main image
      Career growth in medical device regulatory affairs: A recruiter's perspective
    • DEVICE main image
      An accidental profession: Finding your path in medical device regulatory affairs
    • ACADEMIC main image
      Bridging science and compliance: A career path from academia to regulatory medical writing
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • Wegovy IMAGE
      EMA recommends marketing authorisation extension for Wegovy tablets
    • EDQM Image
      Harmonisation, fast track and reliance activities in focus at recent EDQM meetings
    • EMA Pilot Image
      EMA launches pilot to support breakthrough medical devices
  • Commentary
      • Editorials
      • Podcasts
      • Thought leadership
      • Letters to the Editor
    • cover image
      The regulatory profession: Origins, career development and the road ahead
    • Main image
      Access to medicines: From approval to
      patient-centred delivery
    • TOPRA RR JCA 800x533px (6.4 ratio)
      RegRapPod − InConversation with Magda Papadaki
  • Collections
      • Interviews
      • Symposium 2025
      • Symposium 2024
      • Symposium 2023
      • Symposium 2022
      • Symposium 2021
      • Regulatory Careers Live
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items
Pharmaceuticals

November 2024 – Contents

  • No comments

 

RR-Nov-2024-Half-Cover

Regulatory
Rapporteur

 

Write to the Editor at publications@topra.org

November 2024  |  Vol. 21  |  No. 10

 

EDITORIAL

Improving health outcomes through regulatory excellence

Cover option 1 MichaelKipping

READ HERE

By Kornelia Grein, Sobhey Nassar and Marie Uguen

 

HUMAN MEDICINES

Human medicines sessions

SabineHaubenreisser

READ THE SESSION SUMMARIES HERE

 

MEDICAL DEVICES/IVDS

Medical devices/IVDs sessions   

MD1 -MargarethJorvid

READ THE SESSION SUMMARIES HERE

 

VETERINARY MEDICINES

Veterinary medicines sessions

VM1 - RickClayton

READ THE SESSION SUMMARIES HERE

 

PARALLEL SESSION

PS1: Resolving specific development hurdles via scientific advice

PS1 - SandraLourenço

READ HERE

By Ophélie Poujade

 

PARALLEL SESSION

PS2: Patient experience data – The next steps towards medicines evaluation

PS2 - JuanGarciaBurgos

READ HERE

By Anna Koptina

 

SME, ACADEMIA AND START-UPS

SME: Regulatory updates for SME, academia and start-ups

SME -MarjonPasmooij

READ HERE

By Marie Uguen

 

ANNUAL LECTURE

The TOPRA annual lecture: Status of global health  

AnnualLecture - IlonaKickbusch

READ HERE

By Margareth Jorvid

 

Topics

  • 2024
  • Human medicines
  • IVD
  • Medical Devices
  • November 2024
  • Pharmaceuticals
  • Symposium 2024
  • Veterinary
  • No comments

More from Pharmaceuticals

  • SOFT main image
    Journal

    Rethinking regulatory talent development

    2026-05-05T15:05:00Z

    By Philippe Motté and Fidel Torreiro

  • BORDER-main image
    Journal

    Beyond borders: Strengthening regional regulatory frameworks to end substandard and falsified medicines in Africa

    2026-04-09T08:26:00Z

    By Yazaline James

  • HTAR - main image
    Journal

    The EU’s Health Technology Assessment Regulation: Implementation one year on

    2026-03-05T16:15:00Z

    By Billy Amzal

  • AdobeStock_1144819994_RADIO
    Journal

    Regulatory challenges and key considerations in the development of radiopharmaceuticals

    2026-01-14T09:41:00Z

    By Dr Asha Kattige, Dr James Parsley, Dr Hannah Lewis, Dr Maria Beatrice Panico, Dr Lewis Penny and Savannah Orth

  • NSN final image
    Journal

    From laboratory to patient: The role of New Substance Notifications in delivering innovative therapies in Canada

    2025-12-15T12:40:00Z

    By Mary Weedon, Reham Elfarmawy and Rawaa Hussain

  • Falk Ehmann
    Journal

    ​HM2: Fireside chat

    2025-11-18T09:44:00Z

    By Cristina Dragan

Related articles

  • Wegovy IMAGE
    Industry news

    EMA recommends marketing authorisation extension for Wegovy tablets

    2026-06-03T11:56:00Z

    By Sade Astasio

  • EDQM Image
    Industry news

    Harmonisation, fast track and reliance activities in focus at recent EDQM meetings

    2026-05-27T10:40:00Z

    By Janine Jamieson

  • EMA Pilot Image
    Industry news

    EMA launches pilot to support breakthrough medical devices

    2026-05-22T14:09:00Z

    By Sade Astasio

  • CHMP News Image
    Industry news

    Gene therapies, first-in-class medicines and label updates: CHMP delivers a busy April session

    2026-05-21T13:17:00Z

    By Sade Astasio

  • interview_225322
    Journal

    How to build a portfolio career: Stepping beyond the regulatory swim lane

    2026-05-06T11:41:00Z

    By Ming Ewe

  • VET main image
    Journal

    A career in veterinary regulatory affairs: Roles and competencies across the product lifecycle

    2026-05-06T11:28:00Z

    By Kornelia Grein and Birgit Roser

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register
  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2026 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud